Related Experiment Videos
[Study of mdm2 gene amplification in primary breast tumors]
X Fontana1, P Ferrari, M Abbes
1Laboratoire de radioanalyse, centre Antoine-Lacassagne, Nice, France.
Abstract:
mdm2 (mouse double minute) protein seems lead to p53 inactivation and therefore might potentially play a role in carcinogenesis. We have studied mdm2 gene amplification from 239 primary breast cancer tissues. mdm2 gene was amplified in 10% of cases (25/239). mdm2 amplification was associated with c-erbB2 amplification (P < 10(-3)). No other correlation was found. However there was inverse correlation between c-erbB2 gene amplification and hormonal receptors (P < 10(-4)), only from patients without mdm2 gene amplification.
Insights
MDM2 gene amplification, found in 10% of breast cancers, correlates with c-erbB2 amplification. This suggests a potential link between MDM2, c-erbB2, and breast cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The MDM2 (mouse double minute) protein can inactivate p53, a tumor suppressor, suggesting a role in cancer.
- Gene amplification is a known mechanism in carcinogenesis.
Purpose of the Study:
- To investigate the frequency of MDM2 gene amplification in primary breast cancer tissues.
- To explore potential correlations between MDM2 amplification and other genetic alterations or clinical parameters, such as c-erbB2 amplification and hormonal receptor status.
Main Methods:
- Analysis of MDM2 gene amplification in 239 primary breast cancer samples using genetic techniques.
- Statistical analysis to determine correlations between MDM2 amplification, c-erbB2 amplification, and hormonal receptor status.
Main Results:
- MDM2 gene amplification was detected in 10% (25/239) of the primary breast cancer tissues studied.
- A significant association was found between MDM2 gene amplification and c-erbB2 amplification (P < 10(-3)).
- No other correlations involving MDM2 amplification were identified. However, an inverse correlation between c-erbB2 amplification and hormonal receptors was observed in patients lacking MDM2 amplification (P < 10(-4)).
Conclusions:
- MDM2 gene amplification occurs in a subset of primary breast cancers.
- MDM2 amplification is significantly associated with c-erbB2 amplification, indicating a potential co-occurrence in breast tumorigenesis.
- The interplay between MDM2, c-erbB2, and hormonal receptors warrants further investigation in breast cancer.